Evidence map›Paper›PMID 39062482›Full record

ArticleBiomolecules2024

Concentrations of Glypican-4, Irisin and Total Antioxidant Status in Women with Metabolic Syndrome: Influence of Physical Activity.

Teresa Grzelak, Marcelina Sperling, Marta Pelczyńska, Aniceta Ada Mikulska-Sauermann, Paweł Bogdański, Krystyna Czyżewska, Edyta Mądry

Abstract read
In one paragraph

Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Teresa GrzelakChair and Department of Physiology, Poznan University of Medical Sciences, 6 Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0002-2815-0372
Marcelina SperlingDepartment of Medical Chemistry and Laboratory Medicine, Poznan University of Medical Sciences, 8 Rokietnicka Street, 61-701 Poznan, Poland.ORCID 0000-0002-0919-9453
Marta PelczyńskaDepartment of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, 84 Szamarzewskiego Street, 60-569 Poznan, Poland.ORCID 0000-0003-4548-032X
Aniceta Ada Mikulska-SauermannDepartment of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0002-3879-3267
Paweł BogdańskiDepartment of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, 84 Szamarzewskiego Street, 60-569 Poznan, Poland.ORCID 0000-0002-0563-1624
Krystyna CzyżewskaDepartment of Nursing, Stanislaw Staszic State University of Applied Sciences in Pila, 10 Podchorążych Street, 64-920 Pila, Poland.
Edyta MądryChair and Department of Physiology, Poznan University of Medical Sciences, 6 Święcickiego Street, 60-781 Poznan, Poland.ORCID 0000-0002-0081-6558

Funding

Medical Sciences in Poznan 502-01-02228371-04458Medical Sciences in Poznan 502-14-02228371-10315
6 · The paper itself

Abstract

Glypican-4 belongs to a group of poorly understood adipokines, with potential importance in people with metabolic syndrome, especially in groups of patients with glucose metabolism disorder. This study aimed to assess the effect of physical activity on serum glypican-4 and irisin levels and total antioxidant status (TAS) in plasma and saliva in women with metabolic syndrome (MetS). Seventy-two Caucasian women aged 25-60 were included in the study (36 women with MetS and 36 women without MetS (control group, CONTR)). The glypican-4 and irisin concentrations, total antioxidant status, glycemia, lipid profile, anthropometric parameters, and blood pressure were analyzed before and after 28 days of controlled physical activity. Serum glypican-4 and plasma TAS levels were higher (

Indexed as

AntioxidantsExerciseFibronectinsGlypicansMetabolic SyndromeAdultFemaleHumansMiddle AgedWaist-Hip RatioAntioxidantsFibronectinsFNDC5 protein, humanGlypicansanthropometryantioxidant statusglypican-4irisinmetabolic syndromeobesityphysical activity

Identifiers

PMID39062482
PMCPMC11275121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.